Aurora Appoints Joseph del Moral to Board of Directors

TSXV: ACB

VANCOUVER, Oct. 6, 2016 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora" or the "Issuer") (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt:  21P; WKN: A1C4WM) announced today that Mr. Joseph del Moral has been appointed to the Company's Board of Directors.

An innovator in new and emerging industries, Mr. del Moral is co-Founder and CEO of Canadian Cannabis Clinics (CCC). Mr. del Moral is also a co-founder of CanvasRx Inc., Canada's leading cannabis outreach and counselling service provider, where he served as CEO until its acquisition by Aurora.  Prior to his pioneering work in the cannabis industry, Mr. del Moral held several senior positions in the energy industry, including as founder of Newten Home Comfort, before its acquisition by Just Energy in 2010. He holds a B.Comm in Finance from McGill University.

"We are very pleased that Joseph, who has played such a pivotal role in the development of the medical cannabis sector, has agreed to join our Board," said Terry Booth, CEO of Aurora.  "Through his pioneering work at CCC and CanvasRx, he has been instrumental in setting the standards for patients and medical professionals by which Canada's medical cannabis system now operates. With this appointment, Joseph will bring his valuable knowledge, insights and spirit of innovation to Aurora."

Mr. del Moral stated, "The Aurora Standard, with respect to quality, operations and customer care, as well as management's strategic vision for the cannabis sector, are critical elements that differentiate Aurora from other licensed producers. I look forward to helping further establish Aurora's position as a leader in this sector."

On behalf of the Board of Directors,
AURORA CANNABIS INC.

Terry Booth
CEO

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Corporation is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Aurora Cannabis Inc.

Cam Battley, Senior VP, Communications and Medical Affairs, +1.905.864.5525, [email protected], www.auroramj.com; Marc Lakmaaker, NATIONAL Equicom, [email protected], +1.416.848.1397